Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 18/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | XBP1 | P17861 | 1/20 | 0.33 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GALK1 | P51570 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23222876 | 1.00 | PDK2 (0.39) | PDK2MEN1APAF1NPC1LMNA | |
| SCHEMBL18998405 | 1.00 | PDK2 (0.39) | PDK2MEN1APAF1NPC1LMNA | |
| SCHEMBL25121727 | 0.99 | PDK2 (0.37) | PDK2MEN1APAF1NPC1LMNA | |
| SCHEMBL25563727 | 0.98 | PDK2 (0.36) | PDK2MEN1APAF1NPC1LMNA | |
| SCHEMBL25563715 | 0.98 | PDK2 (0.36) | PDK2MEN1APAF1NPC1LMNA | |
| SCHEMBL16810725 | 0.98 | PDK2 (0.36) | PDK2MEN1APAF1NPC1LMNA | |
| SCHEMBL25563713 | 0.98 | PDK2 (0.36) | PDK2MEN1APAF1NPC1LMNA | |
| SCHEMBL23349316 | 0.98 | PDK2 (0.39) | PDK2MEN1APAF1NPC1LMNA | |
| SCHEMBL24905370 | 0.98 | PDK2 (0.39) | PDK2 | |
| SCHEMBL21250662 | 0.98 | PDK2 (0.39) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230108986-A1 | ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-04-06 | — | — | US | disclosed |
| US-20200212301-A1 | SPIROBIFLUORENE DERIVATIVES FOR USE IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200212301-A1 | SPIROBIFLUORENE DERIVATIVES FOR USE IN ELECTRONIC DEVICES | SELE, KCNB2, SCNN1B | PDK2 382/4885MEN1 1092/4885APAF1 3744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.